1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow GSK2646264: new trials by email Literature Review of GSK2646264 trials Research Report on GSK2646264
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264 GSK2646264 0.5% topical cream, GSK2646264 1% topical cream, Placebo - Urticaria | Phase 1 | Completed | GlaxoSmithKline | 34 | 2014-11-17 | 2019-06-21 |
Urticaria (1)
GlaxoSmithKline (1)
Germany (1) · United Kingdom (1)
2014 (1)